Navigation Links
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition

DUBLIN, April 25, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 3rd Edition" report to their offering.


The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter preclinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech provides the reader with the following key benefits:

- In-depth understanding of preclinical stage deal trends since 2007
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of preclinical stage agreements with numerous real life case studies
- Detailed access to actual preclinical stage deals entered into by the leading fifty big pharma and big biotech companies
- Insi

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
3. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
4. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
5. Preclinical data shows 100 percent prevention and treatment of influenza with engineered human antibody
6. Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE)
7. Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
8. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
9. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
10. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
11. Translating Preclinical Pharmacology to Clinical Activity with Myriad RBM’s Inflammation MAP
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup ... to better understand the relationship between weight management and the microbiome. The study uses ... from participants using an iPhone app. , The uBiome app is available as a ...
(Date:10/8/2015)... DIEGO , Oct. 8, 2015  Sorrento ... company developing new treatments for cancer and associated ... Executive Officer, will be presenting at the Aegis ... Las Vegas :Event:Aegis Capital Corporation 2015 Growth ... 2 room, The Encore @ The Wynn in ...
(Date:10/8/2015)... and WAYNE, Pa. , ... and technology consulting firm, has announced the call for ... Pennsylvania , majoring in a life sciences ... a two-year period. In addition, the selected Clarkston Scholar ... mentoring with Clarkston Consulting and participation in Pennsylvania Bio ...
(Date:10/8/2015)... PORTLAND, Oregon , October 8, 2015 /PRNewswire/ ... . --> Global Biologics and Biosimilars ... added a report "Global Biologics and Biosimilars Industry ... Growth, Analysis and Forecast" is a professional and ... Biosimilars industry . ) , ...
Breaking Biology Technology:
... of Interactive, to Head New Division, AUSTIN, ... growth in marketing to customers across the entire ... top 25,independent healthcare firms, has established a full-scale ... will offer clients expanded,digital capabilities, including strategy; web ...
... MedThink Communications, an,innovator in medical communications, brand ... executives to serve the company,s growing,client base ... Steven Palmisano, the new vice president of ... as it integrates creative thinking,and scientific acumen ...
... Modeling Provides Powerful Approach to Modeling Complex ... Biological Systems for Type ... Inc., a systems,biology company focused on identifying molecular mechanisms, ... announced that,its joint collaboration with Sirtris Pharmaceuticals, Inc. (Nasdaq: ...
Cached Biology Technology:
(Date:9/29/2015)... Sept. 29, 2015  iDAvatars is excited to be named ... product to market. The official announcement was recently made at ... event in San Francisco , where iDAvatars ... by IBM Watson. "It is both an honor ... companies to bring to market the cognitive power of IBM ...
(Date:9/28/2015)... NEW YORK , Sept. 28, 2015 /PRNewswire/ ... rate, respiration rate and body temperature, is an ... signs can be indicators of deterioration in a ... the hospital, vital signs are typically taken during ... eight hours. If a patient deteriorates between these ...
(Date:9/28/2015)... 28, 2015 According to a ... Software), Product (Scanner & Others), Application (Access Control & ... Others) & Geography Global - Forecast to 2020", published by ... USD 3627.90 Million by 2020, at a CAGR of ... 65 market data T ables and ...
Breaking Biology News(10 mins):
... Until recently, Etienne Benson, an assistant professor in the University ... trained his academic eye on the history of conservation of ... With his latest publication, however, he consciously chose ... and is certainly smaller. "I wanted to write about ...
... asthma isn,t one of them, shows newly published research led ... Azad, a Banting post-doctoral fellow in the Faculty of Medicine ... investigator on the findings that appeared in the British ... 20 clinical trials in Europe, Australia, New Zealand and Taiwan ...
... and their metabolites within the central nervous system ... Although neuroactive steroids have been shown to improve ... beta (Aβ) peptide-induced neurotoxicity, changes in their level ... cognitive impairment remain elusive given the limitation in ...
Cached Biology News:
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Viruses microRNA Microarray ...
... LTQ XL extends the legendary MSn performance ... generate structural information through Thermo Scientifics innovations ... LTQ XL is the only mass spectrometer ... and CID. Pulsed Q Collision Induced ...
... The reliable and compact GC-8A is Shimadzu's ... Economical and simple to use, the GC-8A ... flow control, on column injection port(s), and ... program models are available. The GC-8A is ...
... The 6820 GC system combines world-class ... Chemical QA/QC software, Agilents world-renowned support and ... consumables and supplies--a combination that lets you ... decisions based on dependable data. The Agilent ...
Biology Products: